---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015013"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:37:21.238452+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience reduces warrant exercise price from $2.85 to $1.20 per share

## Summary
- Effective April 17, 2024, warrant exercise price cut to $1.20 from $2.85 per share.
- Amendment to Warrant Agency Agreement allows future adjustments to lower exercise price.
- Warrants for 3,160,000 shares were issued in August 2023 public offering.
- Company may adjust exercise price lower without holder consent under amended terms.

## SEC filing metadata
- accession: 0001493152-24-015013
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015013/0001493152-24-015013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015013/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015013
- JSON: https://secwatch.observer/filing/0001493152-24-015013.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015013.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. amended Amendment to the Warrant Agent Agreement with Transfer Online, Inc. (effective 2024-04-17).
  - Action: amendment
  - Counterparty: Transfer Online, Inc.
  - Effective: 2024-04-17
  source text: On April 17, 2024, the Company and the Warrant Agent entered into an Amendment to the Warrant Agent Agreement (the “Amendment”) to confirm that the Company may adjust the exercise price of the of the Warrants to provide an exercise price per share that is lower than the then-current exercise price of the Warrants.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015013/0001493152-24-015013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.